Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2024 Jan 9;14:1322332. doi: 10.3389/fphar.2023.1322332

Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo

Shreyas S Kuduvalli 1, Precilla S Daisy 1, Anandraj Vaithy 2, Mugilarasi Purushothaman 3, Arumugam Ramachandran Muralidharan 4,5, Kumar B Agiesh 1, Markus Mezger 6, Justin S Antony 6, Madhu Subramani 7, Biswajit Dubashi 8, Indrani Biswas 1, K P Guruprasad 9, T S Anitha 1,*,
PMCID: PMC10803621  PMID: 38264527

In the published article, there was an error in Table 1. The values of drug doses were inadvertently misrepresented during the final assembly of Table 1. The corrected Table 1 and its caption appear below.

TABLE 1.

The concentration of each drug used in the treatment of animals both individually and in combination.

Groups Drugs Dosage (mg/kg body weight)
Group II Tumor control NA
Group III T 50
Group IV M 80
Group V E 150
Group VI TM 50 + 80
Group VII TE 50 + 150
Group VIII ME 80 + 150
Group IX TME 50 + 80 + 150

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES